Taiwan Biomaterial Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical equipment. It produces foamagen, stroke interventional treatment devices, early degenerative arthritis tissue repair and regeneration products. The company was founded by Hsiao Hsiung Ko, Chun Jen Liao and Wen Hsi Wang on November 12, 2012 and is headquartered in Zhubei, Taiwan.